Vitrolife (Q1 initial take): Largely in line with consensus - Redeye

Vitrolife's Q1 report came in largely in line with consensus showing organic growth of 5% in local currencies, though a -9% FX headwind obscures this in reported SEK terms. We expect making minor downward estimate revisions as the FX-component have been a larger factor than our model assumes. We expect a broadly neutral share price reaction on the report.

Länk till analysen i sin helhet: https://www.redeye.se/research/1159989/vitrolife-q1-initial-take-largely-in-line-with-consensus?utm_source=finwire&utm_medium=RSS